Table 2.
Overview of experimental animal groups.
| Rat line | Sample size | Treatment |
|---|---|---|
| FSL | n = 10 | FMT from patients with MDD (FMT-MDD) |
| n = 10 | FMT from healthy individuals (FMT-Healthy) | |
| n = 10 | Control with autotransplantation of own faeces (CON-Auto) | |
| n = 10 | Control with oral gavage of demineralised water (CON-H2O) | |
| FRL | n = 10 | FMT from patients with MDD (FMT-MDD) |
| n = 10 | FMT from healthy individuals (FMT-Healthy) | |
| n = 10 | FMT from patients with MDD combined with sertraline (FMT-MDD-Ser) | |
| n = 10 | Control with autotransplantation of own faeces (CON-Auto) | |
| n = 10 | Control with oral gavage of demineralised water (CON-H2O) |
FSL (n = 40) and FRL (n = 50) rats were used. Animal groups (n = 10 per group) received either faecal microbiota transplantations (FMT) from patients with MDD (FMT-MDD), FMT from healthy individuals (FMT-Healthy), FMT with their own faeces (CON-Auto) or water by oral gavage (CON-H2O). Additionally, one group of FRL rats received FMT from patients with MDD combined with simultaneous treatment with sertraline (FMT-MDD-Ser).